As of Feb 26
| +2.03 / +3.53%|
The 1 analysts offering 12-month price forecasts for Utah Medical Products Inc have a median target of 61.94, with a high estimate of 61.94 and a low estimate of 61.94. The median estimate represents a +4.12% increase from the last price of 59.49.
The current consensus among 1 polled investment analysts is to Buy stock in Utah Medical Products Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.